{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:23Z","timestamp":1792019783640,"version":"4.4.0"},"reference-count":59,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The cardiovascular implications of non-alcoholic fatty liver disease (NAFLD) have been associated with heart failure with preserved ejection fraction (HFpEF). The purpose of this review was to conduct a bibliographic search regarding the correlation between NAFLD and the echocardiographic parameters of left ventricular diastolic function. A systematic literature search was conducted in PubMed and Embase for original research data reporting on the association of NAFLD with diastolic function markers [E\/e\u2032, left atrial volume index (LAVi), left ventricular mass index (LVMi)]. Meta-analysis was performed using the meta and dmetar packages in R studio v.1.4.1106, with p &lt; 0.05 values being considered significant. Results are expressed as the standardized mean difference (SMD) for continuous variables and as the odds ratio (OR) for categorical variables, with respective 95% confidence intervals (CI). Heterogeneity between studies was expressed with index \u03992. From the preliminary search, 2619 articles were found from which 31 studies were included in the final statistical analysis. The meta-analysis of 8 studies which reported on the prevalence of diastolic dysfunction showed that it was increased in patients with NAFLD (OR: 2.07, 95% CI 1.24\u20133.44 with p = 0.01, I2: 80% with p &lt; 0.01). The meta-analysis of 21 studies showed significantly higher E\/e\u2032 in NAFLD patients (SMD 1.02, 95% CI 0.43\u20131.61 with p &lt; 0.001, I2: 97% with p &lt; 0.001). Individuals with NAFLD had increased LAVi (SMD: 0.87, 95% CI 0.38\u20131.37 with p &lt; 0.001, I2: 96% with p &lt; 0.001) and LVMi (SMD: 0.89, 95% CI 0.31\u20131.48 with p = 0.003, I2: 100% with p &lt; 0.001). To conclude, in the meta-analysis of 31 observational studies, NAFLD patients were found to have affected left ventricular diastolic function, supporting the hypothesis of NAFLD being associated with HFpEF.<\/jats:p>","DOI":"10.3390\/ijms241814292","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T23:11:52Z","timestamp":1695165112000},"page":"14292","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"24","author":[{"given":"Athina","family":"Goliopoulou","sequence":"first","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":false,"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0599","authenticated-orcid":false,"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-8719","authenticated-orcid":false,"given":"Artemis","family":"Anastasiou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-832X","authenticated-orcid":false,"given":"Panteleimon","family":"Pantelidis","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4937-3919","authenticated-orcid":false,"given":"Maria Ioanna","family":"Gounaridi","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-0967","authenticated-orcid":false,"given":"Georgios E.","family":"Zakynthinos","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Katsarou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kassi","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolis","family":"Vavuranakis","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart Failure with Preserved Ejection Fraction In Perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.31083\/j.rcm.2020.04.154","article-title":"Epidemiology and pathogenesis of heart failure with preserved ejection fraction","volume":"21","author":"Nair","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hjc.2016.03.004","article-title":"An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction","volume":"57","author":"Kattel","year":"2016","journal-title":"Hell. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/liv.14600","article-title":"The association of non-alcoholic fatty liver disease and cardiac structure and function\u2014Framingham Heart Study","volume":"40","author":"Chiu","year":"2020","journal-title":"Liver Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of Inflammatory Cytokines with Non-Alcoholic Fatty Liver Disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Theofilis, P., Vordoni, A., Nakas, N., and Kalaitzidis, R.G. (2022). Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Life, 12.","DOI":"10.3390\/life12050718"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tsigkou, V., Oikonomou, E., Anastasiou, A., Lampsas, S., Zakynthinos, G.E., Kalogeras, K., Katsioupa, M., Kapsali, M., Kourampi, I., and Pesiridis, T. (2023). Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054321"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s12350-018-01532-8","article-title":"PET imaging of glucose and fatty acid metabolism for NAFLD patients","volume":"27","author":"Gullberg","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2017.10.016","article-title":"Liver disease and heart failure: Back and forth","volume":"48","author":"Correale","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref_17","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2023, September 14). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https:\/\/www.researchgate.net\/publication\/261773681_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_the_Quality_of_Non-Randomized_Studies_in_Meta-Analysis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.18087\/cardio.2021.5.n1416","article-title":"Early cardiac electrical and structural changes in patients with non-obese non-Alcoholic fatty liver disease","volume":"61","author":"Aksu","year":"2021","journal-title":"Kardiologiya"},{"key":"ref_19","first-page":"143","article-title":"Increased P wave dispersion in patients with liver steatosis","volume":"7","author":"Aparci","year":"2010","journal-title":"Med. Glas"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study","volume":"62","author":"Vanwagner","year":"2015","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc11-1820","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"35","author":"Bonapace","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-015-0187-2","article-title":"Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control","volume":"14","author":"Cassidy","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/echo.14400","article-title":"Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography","volume":"36","author":"Chang","year":"2019","journal-title":"Echocardiography"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction","volume":"272","author":"Chung","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_26","first-page":"457","article-title":"Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease","volume":"17","author":"Fotbolcu","year":"2010","journal-title":"Cardiol. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: Echocardiographic and tissue Doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41387-022-00182-7","article-title":"Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: A cross-sectional analysis","volume":"12","author":"Ismaiel","year":"2022","journal-title":"Nutr. Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/hepr.12770","article-title":"Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population","volume":"47","author":"Jung","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.13005\/bpj\/822","article-title":"Comparison of left ventricular function between patients with non-alcoholic fatty liver disease and healthy individuals","volume":"8","author":"Khoshbaten","year":"2015","journal-title":"Biomed. Pharmacol. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population","volume":"100","author":"Kim","year":"2014","journal-title":"Heart"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20130298","article-title":"Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: A 2D speckle tracking imaging study","volume":"126","author":"Kocabay","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lai, Y.H., Su, C.H., Hung, T.C., Yun, C.H., Tsai, C.T., Yeh, H.I., and Hung, C.L. (2022). Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040916"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4093\/dmj.2019.0001","article-title":"Association between Non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2 diabetes mellitus","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/dom.14310","article-title":"Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes","volume":"23","author":"Lee","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients","volume":"68","author":"Lee","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/echo.14229","article-title":"Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation","volume":"36","author":"Mahfouz","year":"2019","journal-title":"Echocardiography"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Pichiri, I., Bertolini, L., Valbusa, F., Barbieri, E., and Zoppini, G. (2015). Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135329"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_40","first-page":"23","article-title":"Assessment of Left Ventricular Diastolic Function in Young Adults with Nonalcoholic Fatty Liver Disease","volume":"47","author":"Moise","year":"2021","journal-title":"Curr. Health Sci. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"935390","DOI":"10.3389\/fendo.2022.935390","article-title":"Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Left Ventricular Diastolic Function and Cardiac Morphology","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_42","first-page":"20","article-title":"Association between non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in patients of type 2 diabetes","volume":"67","author":"Saluja","year":"2019","journal-title":"J. Assoc. Physicians India"},{"key":"ref_43","first-page":"58","article-title":"Diastolic dysfunction assessment by pulsed-wave and tissue Doppler imaging in diabetic patients with nonalcoholic fatty liver disease","volume":"4","author":"Casoinic","year":"2012","journal-title":"Hum. Vet. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e014279","DOI":"10.1161\/JAHA.119.014279","article-title":"Longitudinal Association of Non-Alcoholic Fatty Liver Disease with Changes in Myocardial Structure and Function: The CARDIA Study","volume":"9","author":"VanWagner","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_46","first-page":"466","article-title":"Assessment of subclinical myocardial changes in non-alcoholic fatty liver disease: A case-control study using speckle tracking echocardiography","volume":"43","author":"Zamirian","year":"2018","journal-title":"Iran. J. Med. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amjcard.2018.10.027","article-title":"Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance","volume":"123","author":"Canada","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e021654","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.amjcard.2021.07.047","article-title":"Independent Association of Fatty Liver Index with Left Ventricular Diastolic Dysfunction in Subjects without Medication","volume":"158","author":"Furuhashi","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_50","first-page":"65","article-title":"Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome","volume":"9","author":"Makker","year":"2019","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11739-022-02966-2","article-title":"Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease","volume":"17","author":"Sonaglioni","year":"2022","journal-title":"Intern. Emerg. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MEG.0000000000000086","article-title":"Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease","volume":"26","author":"Ybarra","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ehf2.13222","article-title":"Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: From pathophysiology to practical issues","volume":"8","author":"Itier","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e003198","DOI":"10.1136\/bmjdrc-2022-003198","article-title":"Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis","volume":"11","author":"Wang","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-022-10319-6","article-title":"Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: A meta-analysis","volume":"16","author":"Yong","year":"2022","journal-title":"Hepatol. Int."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14292\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:53:48Z","timestamp":1760129628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":59,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241814292"],"URL":"https:\/\/doi.org\/10.3390\/ijms241814292","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}